Exagen Inc. Reports Strong Third Quarter 2023 Results
13 nov. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended...
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
09 nov. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced today the...
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
02 nov. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Canaccord...
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
30 oct. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended September 30, 2023,...
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
28 sept. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023...
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
12 sept. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor...
Exagen Inc. Reports Strong Second Quarter 2023 Results
07 août 2023 08h00 HE
|
Exagen Inc.
SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2023. ...
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
30 mai 2023 09h00 HE
|
Exagen Inc.
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43rd Annual Growth...
Exagen Inc. Reports First Quarter 2023 Results
15 mai 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN)("Exagen"), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...
Exagen Announces Campaign for Lupus Awareness Month
01 mai 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a...